Multisector global collaboration to advance the inclusion of pregnant and lactating people in HIV prevention research.
作者信息
Schaefer Robin, Lievense Breanne, Day Suzanne, Donaldson Logan, Bekker Linda-Gail, Chigome Audrey, Kumwenda Grace, Noguchi Lisa, Osakwe Chukwunomso, Miller Veronica, Lyerly Anne Drapkin, Chatani-Gada Manju
机构信息
Forum for Collaborative Research, UC Berkeley School of Public Health, Washington.
AVAC, New York, New York.
出版信息
AIDS. 2025 Oct 1;39(12):1835-1838. doi: 10.1097/QAD.0000000000004257. Epub 2025 Aug 28.
Abstract
摘要
相似文献
1
Multisector global collaboration to advance the inclusion of pregnant and lactating people in HIV prevention research.多部门全球合作，推动将孕妇和哺乳期妇女纳入艾滋病预防研究。
AIDS. 2025 Oct 1;39(12):1835-1838. doi: 10.1097/QAD.0000000000004257. Epub 2025 Aug 28.
2
Exploring optimal folic acid supplementation levels for lactating-pregnant rabbit does with different litter size.探索不同窝产仔数的妊娠-哺乳母兔的最佳叶酸补充水平。
J Anim Sci. 2024 Jan 3;102. doi: 10.1093/jas/skae340.
3
Adherence to option B+ and its association with disclosure status and counseling among HIV-positive pregnant and lactating women in Ethiopia: systematic review and meta-analysis.埃塞俄比亚艾滋病毒呈阳性的孕妇和哺乳期妇女对B+方案的依从性及其与信息披露状况和咨询的关联：系统评价与荟萃分析
Public Health. 2022 Oct;211:105-113. doi: 10.1016/j.puhe.2022.07.016. Epub 2022 Sep 1.
4
Exploring current nutritional programming and resources available to people living with HIV in Canada: a scoping review.探索加拿大艾滋病毒感染者现有的营养规划和资源：范围综述。
JBI Evid Synth. 2023 Oct 1;21(10):2022-2081. doi: 10.11124/JBIES-22-00168.
5
PrEP preferences and early acceptability of injectable cabotegravir among pregnant and lactating people in Cape Town, South Africa: findings from the PrEPared to Choose study.南非开普敦孕妇和哺乳期妇女对注射用卡博特韦的暴露前预防偏好及早期可接受性：“准备好选择”研究的结果
J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26492. doi: 10.1002/jia2.26492.
6
Micronutrient supplementation in pregnant women with HIV infection.对感染艾滋病毒的孕妇进行微量营养素补充
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD009755. doi: 10.1002/14651858.CD009755.
7
Predictors of maternal HIV acquisition during pregnancy and lactation in sub-Saharan Africa: A systematic review and narrative synthesis.撒哈拉以南非洲地区孕期和哺乳期孕产妇感染艾滋病毒的预测因素：一项系统评价和叙述性综合分析
PLoS One. 2024 Dec 3;19(12):e0314747. doi: 10.1371/journal.pone.0314747. eCollection 2024.
8
Pregnancy and lactation alter biomarkers of biotin metabolism in women consuming a controlled diet.怀孕和哺乳会改变食用控制饮食的女性生物素代谢的生物标志物。
J Nutr. 2014 Dec;144(12):1977-84. doi: 10.3945/jn.114.194472. Epub 2014 Aug 13.
9
COVID-19 vaccine preferences for pregnant and lactating women in Bangladesh and Kenya: a qualitative study.孟加拉国和肯尼亚孕妇和哺乳期妇女对 COVID-19 疫苗的偏好：一项定性研究。
Front Public Health. 2024 Aug 14;12:1412878. doi: 10.3389/fpubh.2024.1412878. eCollection 2024.
10
Multisector collaborations at children's hospitals to address social drivers of health.儿童医院开展多部门合作以应对健康的社会驱动因素。
Int J Qual Health Care. 2025 Jul 4;37(3). doi: 10.1093/intqhc/mzaf067.
本文引用的文献
1
Safety and drug quantification of the dapivirine vaginal ring and oral pre-exposure prophylaxis in breastfeeding mother-infant pairs (MTN-043): a phase 3B, open-label, randomised trial.达匹韦林阴道环与口服暴露前预防在母乳喂养母婴对中的安全性及药物定量研究（MTN-043）：一项3B期、开放标签、随机试验
Lancet HIV. 2025 Mar;12(3):e180-e190. doi: 10.1016/S2352-3018(24)00306-0. Epub 2025 Feb 12.
2
Antiretroviral Use for HIV Prevention During Pregnancy: The Need to Strengthen Regulatory and Surveillance Systems in Africa.孕期使用抗逆转录病毒药物预防艾滋病毒：非洲加强监管和监测系统的必要性。
Drug Saf. 2025 Mar;48(3):209-216. doi: 10.1007/s40264-024-01494-6. Epub 2025 Jan 26.
3
Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084.评估长效卡博特韦在非洲东部和南部孕妇中的安全性和药代动力学：HPTN 084的二次分析
J Int AIDS Soc. 2025 Jan;28(1):e26401. doi: 10.1002/jia2.26401.
4
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women.双年度利纳卡帕韦或每日 F/TAF 用于预防 cisgender 女性中的 HIV。
N Engl J Med. 2024 Oct 3;391(13):1179-1192. doi: 10.1056/NEJMoa2407001. Epub 2024 Jul 24.
5
Barriers and facilitators to uptake and use of oral pre-exposure prophylaxis in pregnant and postpartum women: a qualitative meta-synthesis.口服暴露前预防在孕妇和产后妇女中应用的采纳和使用的障碍和促进因素：定性荟萃分析。
BMC Public Health. 2024 Jun 20;24(1):1653. doi: 10.1186/s12889-024-19168-4.
6
Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential.具有生殖潜能的女性使用抗逆转录病毒药物面临的挑战、风险和机遇。
Expert Rev Anti Infect Ther. 2024 Apr;22(4):153-167. doi: 10.1080/14787210.2024.2334054. Epub 2024 Mar 27.
7
DELIVER: A Safety Study of a Dapivirine Vaginal Ring and Oral PrEP for the Prevention of HIV During Pregnancy.DELIVER： 一种用于预防妊娠期间 HIV 感染的地匹福林阴道环和口服暴露前预防的安全性研究。
J Acquir Immune Defic Syndr. 2024 Jan 1;95(1):65-73. doi: 10.1097/QAI.0000000000003312.
8
The way forward in decolonising global health.全球卫生去殖民化的前进道路。
Lancet Glob Health. 2023 Jul;11(7):e982. doi: 10.1016/S2214-109X(23)00275-9.
9
Scientific, ethical, and legal considerations for the inclusion of pregnant people in clinical trials.将孕妇纳入临床试验的科学、伦理和法律考虑因素。
Am J Obstet Gynecol. 2022 Dec;227(6):805-811. doi: 10.1016/j.ajog.2022.07.037. Epub 2022 Aug 4.
10
Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action.加速妊娠中新 HIV 药物的研究：将研究议程从理论推进到实践。
J Int AIDS Soc. 2022 Jul;25 Suppl 2(Suppl 2):e25912. doi: 10.1002/jia2.25912.
Zotero 插件